, Volume 20, Issue 4, pp 506-508
Date: 02 Feb 2010

Long-Term Results of Gastric Bypass Surgery in Morbidly Obese Type 1 Diabetes Patients

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access



Long-term effects of bariatric surgery in morbidly obese type 1 patients are unknown. Five to eight-year experience in the case series of type 1 diabetes subjects is presented.


Three poorly controlled type 1 diabetes patients, aged 19, 23, and 28 underwent Roux-en-Y gastric bypass surgery.


Their maximum body weight reduction noted during the follow-up was between 27% and 31% of baseline body weight, insulin requirement decreased from 0.6–0.95 to 0.3–0.83 IU/kg, and absolute reduction in HbA1c was 3–4%. Significant improvement in blood pressure, plasma lipid profile, and microalbuminuria was noted.


RYGB surgery in morbidly obese type 1 diabetes patients leads to a significant and maintained weight loss and results in remarkable improvement in blood glucose control and concomitant disorders. Bariatric surgery should be recommended to significantly obese type 1 diabetes patients as a means of reduction of vascular complications risk.